Ovarian reserve is a complex clinical phenomenon influenced by age, genetics, and
environmental variables. Although it is challenging to predict the rate of an individual's …

BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been
applied to a wide array of clinical applications, mainly based on its ability to reflect the …

BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

The polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility
and a notable proportion of women of reproductive age are affected. It may constitute a risk …

Ovarian reserve is defined as the number of oocytes remaining in the ovary, or oocyte
quantity (oocyte number). Markers of ovarian reserve include hormone levels and …

Context: Endometriomas are mainly treated surgically. However, there has been concern
over the potential damaging effect of this surgery on ovarian reserve. Objective: The aim of …

Menopause is the final step in the process referred to as ovarian ageing. The age related
decrease in follicle numbers dictates the onset of cycle irregularity and the final cessation of …

Oocyte number and quality decline with age; however, fertility varies significantly even
among women of the same age. Various measures have been developed to predict …

Diagnostic evaluation for infertility in women should be conducted in a systematic,
expeditious, and cost-effective manner to identify all relevant factors with initial emphasis on …

BACKGROUND In women, anti-Müllerian hormone (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …